The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Monyse de Nóbrega Mariana Bisarro Dos Reis Érica Romão Pereira Marilesia Ferreira de Souza Ilce Mara de Syllos Cólus

Published in: Journal of cancer research and clinical oncology (2022)

Cell-free and exomiRNAs in serum or plasma are promising tools for be used as non-invasive biomarkers for diagnostic, prognosis, therapy improvement and clinical outcome prediction in PCa patients.

Keyphrases

cell free
prostate cancer
end stage renal disease
circulating tumor
newly diagnosed
ejection fraction
peritoneal dialysis
radical prostatectomy
prognostic factors
stem cells
ionic liquid
patient reported outcomes
risk assessment
climate change
circulating tumor cells
replacement therapy